Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

About 25% of Americans have a health insurance plan that covers these weight loss drugs, according to the AXIACI Obesity Coverage Nexus, a database produced by the Leverage consulting firm.

The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.

Medicare, by statute, is still prohibited from paying for the use of obesity medications — a policy that is discriminatory and a reflection of the stigmatization of obesity. The popular focus on ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications. More than an estimated million Floridians are now using weight-loss medications, and experts ...

In a world grappling with obesity and chronic disease, GLP-1 drugs like Ozempic are emerging as transformative game-changers.